Suresh K. Durgam, a newly appointed director at Helus Pharma Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 2, 2026, disclosing no securities beneficially owned as of the October 16, 2026 triggering event.

Key Highlights

  • Reporting person: Durgam Suresh K. is identified as a Director of Helus Pharma Inc. (NASDAQ:HELP).
  • Triggering event date: The date of the event requiring the statement is October 16, 2026.
  • No securities held: According to the filing, "No securities are beneficially owned" by the reporting person.
  • Non-derivative table: Table I, covering non-derivative securities, contains no entries.
  • Derivative table: Table II, covering derivative securities such as options, warrants, and convertible securities, also contains no entries.
  • Filing type: The form is filed by one reporting person and is not an amendment.
  • Signature date: The form was signed on October 31, 2026.

Durgam Suresh K. Reports Zero Beneficial Ownership Upon Joining Helus Pharma Board

Suresh K. Durgam filed a Form 3 Initial Statement of Beneficial Ownership with the U.S. Securities and Exchange Commission in connection with his role as a Director of Helus Pharma Inc., listed on NASDAQ under the ticker HELP. The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires certain insiders to disclose their initial beneficial ownership of issuer securities upon first becoming subject to Section 16 reporting obligations.

According to the filing, the date of the event requiring the statement was October 16, 2026. The reporting person's address is listed as c/o Helus Pharma Inc., 100 King Street W., Suite 5600, Toronto, Ontario, Canada, M5X 1C9. The filing states explicitly that "No securities are beneficially owned," meaning both Table I (non-derivative securities) and Table II (derivative securities, including puts, calls, warrants, options, and convertible securities) were left blank, with no entries recorded in either table.

The form was filed by one reporting person and is not identified as an amendment to a prior filing. It was signed by Suresh Durgam on October 31, 2026, and submitted to the SEC on November 2, 2026. No explanation of responses beyond the "No securities are beneficially owned" notation was included in the filing.

What Was Disclosed

Suresh K. Durgam, a Director of Helus Pharma Inc. (NASDAQ:HELP), filed an initial beneficial ownership statement disclosing that he holds no securities, either direct or indirect, derivative or non-derivative, in the company as of October 16, 2026.